Alpen Pharma Symposium at ISIAN & IRS 2024 Congress

42nd ISIAN and the 24th IRS (ISIAN & IRS 2024), April 4 – 6, 2024 Tokyo, Japan

From April 4 to 6, 2024 in Tokyo, Japan was held ISIAN & IRS 2024 Congress.

Alpen Pharma Group had the great opportunity to participate in these two traditional respected congresses and to expand the scientific partnership and collaboration with key opinion leaders among the ENT community.

ISIAN & IRS 2024 has brought together more than 900 leading and influential representatives of this field from various countries.

At the congress in Tokyo, we organized a significant event – Alpen Pharma Symposium that took place on 05 April, where we presented the features, capabilities and scientific evidence of the effectiveness and safety of the Cinnabsin as a natural treatment support in the field of rhinosinusitis.

The Topic of the symposium was: Natural remedies for sinonasal infections and inflammation effectively provide quick relief of symptoms and optimization of long-term treatment.

We had the honor to have the following world known and respected lecturers and moderators:

Dr. Martin Desrosiers MD FRCSC, Sinus Surgeon, Centre Hospitalier Université de Montréal, Clinical Professor, Université de Montréal, Clinical Researcher, CRCHUM: The “Living Sinus Laboratory”.

Prof. Vicheva – President of the ERS 2023-2025, Department of Otorhinolaryngology, Medical University of Plovdiv, Bulgaria; ENT clinic, University hospital “Kaspela”, Plovdiv, Bulgaria

Dr. Kawauchi – Hideyuki Kawauchi,MD,DMSc. Department of Microbiology, Faculty of Medicine, Shimane University, Japan

Moderators:

Prof. Valerie Lund – Dame Valerie Joan Lund DBE MS FRCS, a British surgeon and emeritus Professor in Rhinology at University College London, who was elevated from CBE to DBE in the 2024 New Year Honors.

Dr. Robert Kern – Chair, Department of Otolaryngology – Head and Neck Surgery George A. Sisson, MD, Professor of Otolaryngology – Head and Neck Surgery and Medicine (Allergy and Immunology).

Moderators and participants of the symposium were satisfied to hear all scientific data and made the conclusion that such a seminar creates an appropriate environment for discussions, exchange of knowledge, advancements and ideas for further research and publications related to Cinnabsin, as well as for its full application in the complex treatment of rhinosinusitis.

During the ISIAN & IRS 2024 Congress Alpen Pharma Group also participated in the exhibition space, as its exhibition booth featured a very beautiful and attractive appearance, professional scientific materials, video presentation and elegant gifts.

This congress was a valuable and enlightening experience, and we hope this will bring a lot of possibilities for the future development of the company and its products.